Aldeyra Therapeutics (ALDX) Net Equity Issued and Repurchased (2013 - 2026)
Aldeyra Therapeutics (ALDX) posted Net Equity Issued and Repurchased of $71,140 for Q1 2026, down 92.8% from $983,194 a year earlier.
Aldeyra Therapeutics (ALDX) Net Equity Issued and Repurchased (2013 - 2026) Analysis & Trends
For FY2025, Aldeyra Therapeutics' Net Equity Issued and Repurchased came in at $1.1 million, up 215.2% from FY2024.
- Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -51.4% (FY2020 to FY2025).
- In prior years, Aldeyra Therapeutics' Net Equity Issued and Repurchased was $350,279 in FY2024 (+80.4%), $194,129 in FY2023 (-82.7%), $1.12 million in FY2022 (-99.4%) and $189.81 million in FY2021 (+366.2%).
- The Q1 2026 figure stands as the lowest quarterly Net Equity Issued and Repurchased since Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Aldeyra Therapeutics | 74.19 Mn | 74.19 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 71,140.00 |
| Sep 30, 2025 | 120,746.00 |
| Mar 31, 2025 | 983,194.00 |
| Dec 31, 2024 | 567,540.00 |
| Sep 30, 2024 | -235,452.00 |
| Mar 31, 2024 | 18,191.00 |
| Dec 31, 2023 | 30,188.00 |
| Sep 30, 2023 | 111,382.00 |
| Mar 31, 2023 | 52,559.00 |
| Sep 30, 2022 | 1.10 Mn |
| Mar 31, 2022 | 23,324.00 |
| Jun 30, 2021 | 119.76 Mn |
| Mar 31, 2021 | 70.05 Mn |
| Dec 31, 2020 | 1.00 |
| Sep 30, 2020 | 25.17 Mn |
| Jun 30, 2020 | 12.37 Mn |
| Mar 31, 2020 | 3.17 Mn |
| Dec 31, 2019 | 7.17 Mn |
| Jun 30, 2019 | -86,643.00 |
| Mar 31, 2019 | 807,607.00 |
Aldeyra Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ALDX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ALDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ALDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();